The Chinese government must publicize the prices of medicines andmedical products, and related policies, five to seven days before they take effect, according to an announcement by the State Development Planning Commission, reported by Xinhua.
This development is aimed at improving the timeliness and transparency of the government's pricing policies and enhancing public supervision over drug prices, it says, adding that the Commission has designated a number of pharmaceutical, medical and business journals to carry these announcements, plus two web sites, www.cei.gov.cn and www.cpic.govc.con.
In a communication to local governments, the Commission warns that all manufacturers and hospitals must adhere rigidly to the official policies and prices released through the designated media, or be penalized by the price supervision authorities.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze